-0.02 | -4.44%
| Price and Volume | |
|---|---|
| Recent Price | 0.45 |
| 52 Week High | 0.64 |
| 52 Week Low | 0.26 |
| Avg. Daily Vol. (Mil) | 0.02 |
| Beta (3 year) | 0.83 |
| Share Related Items | |
| Mkt Cap (Mil) | 25.66 |
| Shares Out (Mil) | 57.03 |
| Float (Mil) | 44.30 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 6.90 |
| Current Ratio | 7.00 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 10.68 |
| Price/Cash Flow | -11.90 |
| Per Share Data | |
| Earnings | -0.04 |
| Sales | 0.00 |
| Book Value | 0.04 |
| Cash Flow | -0.04 |
| Business Summary | |
|---|---|
| It is a pharmaceutical Company engaged in the research and development of innovative pharmaceutical solutions, including an orally ingestible insulin capsule or tablet. | |
| General Information | |
| Hi-Tech Park 2/5 Givat Ram
PO Box 39098 Jerusalem, 91390 |
|
| 0.99999999996914 | |
| www.oramed.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 8 | |
| CEO: Nadav Kiron | |
| Short Interest | |
| Current Month (Mil) | 0.00 |
| Previous Month (Mil) | 0.00 |
| Short Interest Ratio (Days) | 0.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -73.80 |
| Return on Investments | -90.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,779.17 | 1,165.82 | 2,391.28 | 36.72 |
Oil *
81.41
|
|
UP
45.50
|
DOWN
0.39
|
UP
2.19
|
UP
0.30
|
10 Yr
3.67%
SPDR Gold
110.34
|
|
+0.42%
|
-0.03%
|
+0.09%
|
+0.82%
|
Data delayed 20 minutes |
Connect with TheStreet